Global Oral Biologics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Drug Class;
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist, Hormone, Recombinant Enzyme, Guanylate Cyclase-C Agonist, Somatostatin Analogue and Others.Segmented by Disease Indication;
Diabetes, Hyperoxaluria, Acromegaly, Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC), Others (Inflammatory Bowel Disease (IBD) and Hypoparathyroidism and Others).Segmented by Distribution Channel;
Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Oral Biologics Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 72.0 |
2021 | 84.4 |
2022 | 95.7 |
2023 | 107.9 |
2024 | 111.0 |
2025 | 127.5 |
2026 | 148.7 |
2027 | 163.3 |
2028 | 188.0 |
2029 | 205.7 |
2030 | 226.8 |
In the year 2023, the Global Oral Biologics Market was valued at USD 2,432.13 million. The size of this market is expected to increase to USD 19,752.43 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 34.9%.
Global Oral Biologics Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Oral Biologics Market |
Study Period | 2020 - 2030 |
Base Year (for Oral Biologics Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Oral Biologics Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Oral Biologics Market Analysis
In this report, the Global Oral Biologics Market has been segmented by Drug Class, Disease Indication, Distribution Channel and Geography. Biologics are currently one of the most promising therapeutic interventions in conditions such as metabolic disease, ageing, and inflammatory disorders, and oral delivery of such medicines has long been recognised as an important goal for chronic ailments. Biologics cannot currently be administered orally. The gastrointestinal tract's barriers severely limit biologics' systemic absorption.
Global Oral Biologics Market, Segmentation by Drug Class
The Global Oral Biologics Market has been segmented by Drug Class into Glucagon-like Peptide 1 (GLP-1) Receptor Agonist, Hormone, Recombinant Enzyme, Guanylate Cyclase-C Agonist, Somatostatin Analogue and Others. The complete Global Oral Biologics Market segmentation by Drug Class can be seen below:
- Global Oral Biologics Market,By Drug Class
- Glucagon-like Peptide 1 (GLP-1) Receptor Agonist
- Hormone
- Recombinant Enzyme
- Guanylate Cyclase-C Agonist
- Somatostatin Analogue
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Drug Classs mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Drug Class is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oral Biologics Market, by Drug Class (USD Million), 2020 - 2030
# | Glucagon-like Peptide 1 (GLP-1) Receptor Agonist | Hormone | Recombinant Enzyme | Guanylate Cyclase-C Agonist | Somatostatin Analogue | Others |
---|---|---|---|---|---|---|
2020 | 56.9 | 63.1 | 77.4 | 100.8 | 82.8 | 85.0 |
2021 | 66.5 | 69.3 | 91.8 | 104.1 | 83.8 | 95.2 |
2022 | 78.4 | 70.1 | 97.5 | 104.3 | 96.7 | 97.6 |
2023 | 83.1 | 83.5 | 114.7 | 105.3 | 113.2 | 112.6 |
2024 | 85.5 | 97.9 | 131.0 | 123.9 | 131.8 | 112.8 |
2025 | 97.5 | 99.1 | 141.8 | 147.7 | 140.3 | 119.4 |
2026 | 104.3 | 115.7 | 154.1 | 166.5 | 150.1 | 135.5 |
2027 | 116.2 | 122.3 | 158.6 | 177.9 | 176.0 | 137.8 |
2028 | 128.4 | 130.8 | 184.6 | 179.3 | 204.9 | 164.4 |
2029 | 146.8 | 156.2 | 196.4 | 199.4 | 212.0 | 195.8 |
2030 | 164.4 | 171.8 | 216.3 | 236.8 | 231.3 | 230.7 |
Global Oral Biologics Market, Segmentation by Disease Indication
The Global Oral Biologics Market has been segmented by Disease Indication into Diabetes, Hyperoxaluria, Acromegaly, Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC) and Others (Inflammatory Bowel Disease (IBD). The complete Global Oral Biologics Market segmentation by Disease Indication can be seen below:
- Global Oral Biologics Market, By Disease Indication
- Diabetes
- Hyperoxaluria
- Acromegaly
- Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC)
- Others (Inflammatory Bowel Disease (IBD), Hypoparathyroidism and Others)
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Disease Indications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Disease Indication is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oral Biologics Market, by Disease Indication (USD Million), 2020 - 2030
# | Diabetes | Hyperoxaluria | Acromegaly | Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC) | Others (Inflammatory Bowel Disease (IBD), Hypoparathyroidism and Others) |
---|---|---|---|---|---|
2020 | 68.5 | 72.3 | 107.4 | 82.5 | 76.6 |
2021 | 79.9 | 72.6 | 124.9 | 94.8 | 86.3 |
2022 | 90.0 | 82.5 | 132.2 | 109.5 | 99.7 |
2023 | 92.7 | 87.7 | 142.5 | 114.9 | 108.1 |
2024 | 109.3 | 90.1 | 167.4 | 132.2 | 124.1 |
2025 | 122.9 | 103.6 | 182.1 | 138.9 | 139.5 |
2026 | 146.0 | 109.0 | 211.4 | 141.7 | 153.6 |
2027 | 158.9 | 124.1 | 236.8 | 166.9 | 180.6 |
2028 | 190.1 | 146.0 | 240.9 | 179.4 | 192.0 |
2029 | 212.6 | 160.5 | 241.9 | 194.0 | 217.0 |
2030 | 214.4 | 175.7 | 282.6 | 226.8 | 223.3 |
Global Oral Biologics Market, Segmentation by Distribution Channel
The Global Oral Biologics Market has been segmented by Distribution Channel into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. The complete Global Oral Biologics Market segmentation by Distribution Channel can be seen below:
- Global Oral Biologics Market,By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Distribution Channels mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Distribution Channel is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oral Biologics Market, by Distribution Channel (USD Million), 2020 - 2030
# | Hospital Pharmacies | Retail Pharmacies | Online Pharmacies |
---|---|---|---|
2020 | 65.3 | 101.8 | 81.0 |
2021 | 67.5 | 119.2 | 84.5 |
2022 | 69.1 | 122.4 | 87.9 |
2023 | 72.4 | 123.5 | 96.0 |
2024 | 76.1 | 144.5 | 99.9 |
2025 | 86.5 | 145.2 | 117.6 |
2026 | 102.2 | 161.2 | 125.9 |
2027 | 114.6 | 179.7 | 149.3 |
2028 | 118.8 | 184.5 | 156.5 |
2029 | 138.0 | 205.5 | 157.7 |
2030 | 155.2 | 210.2 | 189.1 |
Global Oral Biologics Market, Segmentation by Geography
In this report, the Global Oral Biologics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Oral Biologics Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Oral Biologics Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Oral Biologics in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Oral Biologics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Oral Biologics Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Oral Biologics Market will be discussed in detail in the full report.
- The new opportunities in Global Oral Biologics Market will be discussed in detail in the full report.
- Global Oral Biologics Market Drivers will be discussed in detail in the full report.
- Global Oral Biologics Market Restraints will be discussed in detail in the full report.
- Global Oral Biologics Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Oral Biologics Market. The opportunity map (by market segments; Drug Class, Disease Indication and Distribution Channel) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Oral Biologics Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Oral Biologics Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Oral Biologics Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Oral Biologics Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Oral Biologics Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Oral Biologics Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Oral Biologics Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Oral Biologics Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Oral Biologics Market include, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals, Inc., Rani Therapeutics, Entera Bio Ltd., Allergan plc, Emisphere Technologies and Enteris BioPharma.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Disease Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Opportunity Map
- Global Oral Biologics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Oral Biologics Market,By Drug Class, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Glucagon-like Peptide 1 (GLP-1) Receptor Agonist
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hormone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Recombinant Enzyme
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Guanylate Cyclase-C Agonist
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Somatostatin Analogue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Glucagon-like Peptide 1 (GLP-1) Receptor Agonist
- Global Oral Biologics Market, By Disease Indication, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hyperoxaluria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Acromegaly
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others (Inflammatory Bowel Disease (IBD), Hypoparathyroidism and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Diabetes
- Global Oral Biologics Market,By Distribution Channel, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hospital Pharmacies
- Global Oral Biologics Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Oral Biologics Market,By Drug Class, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Novo Nordisk A/S
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Biocon Limited
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Oramed Pharmaceuticals, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Rani Therapeutics
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Entera Bio Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Allergan plc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Emisphere Technologies, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Enteris BioPharma, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novo Nordisk A/S
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Organ Preservation Solutions Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Orthodontics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Orthopedic Braces and Supports Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Oral Proteins and Peptides Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%